Jim Cramer Says AI Is Back & Discusses These 10 Stocks

8. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders In Q4 2024: 115

Eli Lilly and Company (NYSE:LLY) is one of Jim Cramer’s favorite pharmaceutical and healthcare stocks. In several appearances, the CNBC host has pointed out that the firm’s non-weight loss drug portfolio and sizable manufacturing investments can create compelling tailwinds for the stock. Cramer also believes that the weight loss drug market is now dependent on a pill, and his latest comments about Eli Lilly and Company (NYSE:LLY) built on this hypothesis:

“Well I mean Dave Ricks was on and really, there was some research this morning that said look really it’s only going to be about two, three percent that ultimately it gets steered to Wegovy. Look, if you go back to the last quarter, Lilly had the same thing happen. Lilly just does not guide aggressively. David Ricks is very conservative. The stock tends to go down more than six, seven, it tends to go down eight, nine, and then you gotta start buying it. We’ve been going through this. We own it through the trust. This is like the third time we’ve had to deal with this. But in the end, what David Ricks said, that was the most important thing, is they have the pill. And the pill mean two hundred million people overseas. Look, you can’t use that, the injector’s gotta be kept cold, people don’t like to take a shot. Whoever has the pill, is going to be the winner.”

“To me, this one where you’ve literally got a CEO, who is the least promotional, Carl this guy’s the least promotional CEO I have ever, really self-effacing.”

“But I love the fact that they are just talking about these markets, like China, India. And how when you get the pill, they’re gonna go all over. He did not talk too much about the claims. They were trying to bait him into saying more things. But there are so many studies out that are going to indicate that it’s just . . .a longer life pill.”

“Well David Ricks would tell you, look the studies of hypertension. Look in the end, it’s going to Alzheimer’s and cancer. What does it do for those?”